A. Viala

发表

Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patients

F. Bellisle, M. Bourdel, J. Olié, 2009, International clinical psychopharmacology.

Psychiatric symptoms and mortality in older adults with major psychiatric disorders: results from a multicenter study

M. Leboyer, N. Hoertel, C. Blanco, 2022, European Archives of Psychiatry and Clinical Neuroscience.

Ghrelin and leptin levels in schizophrenic patients treated with antipsychotic monotherapy.

M. Bourdel, J. Olié, J. Epelbaum, 2009, Journal of clinical psychopharmacology.

[Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].

A. Viala, P. Martin, H. Bardou, 2005, L'Encephale.

Pharmacoclinical correlations in schizophrenic patients treated with haloperidol decanoate: Clinical evaluations, concentrations of plasma and red blood cell haloperidol and its reduced metabolite, and plasma homovanillic acid

N. Aymard, A. Viala, F. Caroli, 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

A comprehensive model of predictors of quality of life in older adults with schizophrenia: results from the CSA study

M. Leboyer, C. Blanco, N. Hoertel, 2020, Social Psychiatry and Psychiatric Epidemiology.

Psychiatric symptoms and quality of life in older adults with schizophrenia spectrum disorder: results from a multicenter study

M. Leboyer, C. Blanco, N. Hoertel, 2019, European Archives of Psychiatry and Clinical Neuroscience.

Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone Plasma and red blood cell concentrations of risperidone and its 9-hydroxymetabolite and their relationship to whole blood serotonin and tryptophan, plasma homovanillic acid, 5-hydroxyindoleacetic acid, dihydroxyp

J. Gauillard, M. Vacheron, N. Aymard, 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Association of an UCP4 (SLC25A27) haplotype with ultra-resistant schizophrenia.

B. Millet, M. Krebs, O. Kebir, 2011, Pharmacogenomics.

Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: Clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophan

M. Vacheron, N. Aymard, A. Viala, 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The effectiveness of a psycho‐educational group after early‐stage breast cancer treatment: results of a randomized French study

P. Hardy, A. Brédart, S. Dolbeault, 2009, Psycho-oncology.

Psychiatric symptoms and mortality in older adults with major psychiatric disorders: results from a multicenter study

M. Leboyer, N. Hoertel, C. Blanco, 2022, European Archives of Psychiatry and Clinical Neuroscience.

Treatment Adherence with Early Prescription of Long-Acting Injectable Antipsychotics in Recent-Onset Schizophrenia

M. Vacheron, A. Viala, F. Cornic, 2012, Schizophrenia research and treatment.

Psychotic patients addicted to cannabis and other substances treated with risperidone long acting injectable: Follow-up and reintegration

A. Viala, F. Caroli, P. Martin, 2007, European Psychiatry.

A descriptive, open-label, long-term follow-up survey of psychotic patients receiving risperidone long-acting injectable: Preliminary results

Pascal Martin, S. Cheref, J. Gauillard, 2009, International journal of psychiatry in clinical practice.

Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: Clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophan

M. Vacheron, N. Aymard, A. Viala, 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.